glp-1 news today november 5 2025 GLP-1 Pipeline Update: November 2025 - Prime Therapeutics

There's a surprising new benefit from taking GLP-1 weight loss drugs—using the medication is associated with lower breast cancer incidents, according to a published study. Latest Medical Watch Daily Digest: ( https://wgntv.com/news/medical-watch/glp-1

29.92

★★★★☆4.8 (126)

ISPOR 2025: Exploring reasons for GLP-1 discontinuation

26.98

★★★★★4.9 (98)

GLP-1 Receptor Agonist Market Growth Analysis

24.67

★★★★★5.0 (157)

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity November 5, 2025 DOI: 10.1056/NEJMdo008238 New for the treatment of obesity - and so many additional indications being studied

25.20

★★★★★4.7 (84)

GLP-1 Agonists Market Report 2025-2033, By Product, Molecule, and Geo

25.60

★★★★★4.9 (203)

Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford

27.57

★★★★★5.0 (176)

Covering GLP-1 Drugs: Employers' Top Questions Answered – Sequoia

20.80

★★★★★4.8 (132)